DaunoXome liposomal daunorubicin data

NXTR announced that Phase II findings presented at the Chemotherapy Foundation

Read the full 112 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE